VP38 Changes to glucocorticosteroid prescribing patterns in Duchenne muscular dystrophy in the UK over the last decade

This study aims to describe changes in UK prescribing patterns of GCs between 2012-2022 and differences in side effects between groups. The NorthStar database prospectively collects longitudinal data from all children with DMD followed in all 24 UK paediatric neuromuscular centres. Data on GC usage was available for 1096 patients, across 6521 observations; 800 patients (73%) were taking GCs.

Source: Neuromuscular Disorders - October 1, 2023 Category: Neurology Authors: G. Landon, G. Stimpson, A. Sarkozy, A. Manzur, M. Guglieri, F. Muntoni, G. Baranello Source Type: research